| Lineage |
Neuron > Serotonergic |
| Markers |
TPH2, SLC6A4, SLC18A2, HTR1A, HTR2A, PET1, LMX1B |
| Brain Regions |
Dorsal raphe nucleus, Median raphe nucleus, Brainstem |
| Disease Vulnerability |
Parkinson's Disease, Alzheimer's Disease, Depression, FTD |
Serotonin Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Serotonin Neurons are specialized neuroendocrine cells that produce and release the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT).[1] These neurons are primarily located in the raphe nuclei of the brainstem and project diffusely to virtually all brain regions, making them central modulators of brain function.[2]
Serotonin neurons play crucial roles in regulating mood, sleep, appetite, cognition, and pain perception. Their widespread projections allow them to influence virtually every aspect of brain function.[3]
Serotonin neurons are identified by expression of:
- TPH2 - Tryptophan hydroxylase 2, the rate-limiting enzyme for serotonin synthesis
- SLC6A4 - Serotonin transporter (SERT)
- SLC18A2 - Vesicular monoamine transporter 2 (VMAT2)
- HTR1A - Serotonin 1A receptor (autoreceptor)
- HTR2A - Serotonin 2A receptor
- PET1 - Transcription factor specific to serotonin neurons
- LMX1B - Lim homeobox transcription factor
Serotonin neurons are located primarily in the raphe nuclei and perform essential functions:
- Synthesize and release serotonin as a modulatory neurotransmitter
- Utilize TPH2 as the brain-specific tryptophan hydroxylase[4]
- Express VMAT2 for vesicular packaging of serotonin
- Provide diffuse ascending projections to cortex, hippocampus, and basal ganglia
- Modulate neuronal excitability and synaptic transmission
- Regulate release of other neurotransmitters (glutamate, GABA, dopamine)
- Mood and emotional state regulation
- Sleep-wake cycle control
- Appetite and satiety signaling
- Pain perception modulation
- Cognitive functions including learning and memory
Serotonin neurons are affected in PD:
- 5-HT neuron loss: Degeneration of serotonergic neurons in PD brainstem[5]
- Motor complications: Serotonin neurons contribute to levodopa-induced dyskinesias[6]
- Non-motor symptoms: Serotonergic dysfunction contributes to depression, sleep disorders, and autonomic dysfunction in PD[7]
- Alpha-synuclein pathology: Serotonin neurons accumulate Lewy bodies[8]
- Serotonergic hypofunction: Reduced serotonin markers in AD cortex[9]
- Mood symptoms: Serotonergic dysfunction contributes to depression in AD
- Cognitive impairment: 5-HT modulation affects memory and attention
- Therapeutic targeting: SSRIs show some efficacy in AD symptoms[10]
- Core pathology: Serotonin neuron dysfunction is central to depression pathophysiology
- Treatment target: SSRIs and SNRIs increase synaptic serotonin
- Neurogenesis: Serotonin promotes adult hippocampal neurogenesis
- Serotonergic alterations in FTD
- Contribute to neuropsychiatric symptoms
- Interact with tau pathology
- SSRIs: Selective serotonin reuptake inhibitors (fluoxetine, sertraline)
- SNRIs: Serotonin-norepinephrine reuptake inhibitors
- 5-HT1A agonists: Buspirone and related compounds
- Triptans: 5-HT1B/1D agonists for migraine
- Deep brain stimulation: Raphe nuclei stimulation
- Gene therapy: TPH2 expression restoration
- Cell transplantation: Serotonin neuron precursors
- Psychedelics: 5-HT2A agonists show promise in preclinical models
The study of Serotonin Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Jacobs BL, Azmitia EC. Structure and function of the brain serotonergic system. Physiol Rev. 1992;72(1):165-229.
- Descarries L, et al. Regional and laminar distribution of the serotonin and dopamine innervation in the adult rat cerebral cortex. Neuroscience. 2010;171:329-343.
- Berger M, et al. The expanded biology of serotonin. Annu Rev Med. 2009;60:355-366.
- Walther DJ, et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 2003;299(5603):76.
- Halliday GM, et al. Neuropathology of serotonergic neurons in Parkinson's disease. Mov Disord. 1990;5(3):230-234.
- Carta M, et al. Serotonergic regulation of motor corticostriatal plasticity. Neuroscience. 2007;144(1):165-174.
- Politis M, Niccolini F. Serotonin in Parkinson's disease. Behav Brain Res. 2015;277:136-145.
- Jellinger KA. Pathology of Parkinson's disease. Mol Chem Neuropathol. 1991;14(3):153-197.
- Palmer AM, et al. Neurotransmitter abnormalities in Alzheimer's disease. Lancet. 1987;1(8534):684.
- Lyketsos CG, et al. Treating depression in Alzheimer disease: efficacy and safety of sertraline and venlafaxine. Am J Geriatr Psychiatry. 2006;14(5):469-477.